Tuesday, January 16, 2024

Aspen Neuroscience Sets Regulatory head

San Diego-based Aspen Neuroscience, a biotechnology company which is developing treatments for Parkinson's disease, says it has named Ana Sousa, MSJ, as the company's Chief Regulatory Officer. Sousa has been the company's Senior Vice President of Regulatory and Quality since 2021. Aspen Neuroscience says it has worked at such companies as Roche/Genentech, Onyx/Amgen, Principia Biopharma (Sanofi) as well as several startups.